» Subscribe Today!
More of what you want to know.
The Daily News
X

Forgot your password?
Skip Navigation LinksHome >
VOL. 129 | NO. 95 | Thursday, May 15, 2014

ZeroTo510 Names New Participants

By Andy Meek

Print | Front Page | Email this story | Email reporter | Comments ()

Four teams have been chosen to participate in the 2014 ZeroTo510 medical device accelerator and started the 12-week program, now in its third year, at the Memphis Bioworks Business Incubator this week.

The participants are Blood Monitoring Solutions, EndoInsight, Innometrix and Compression Kinetics.

Blood Monitoring Solutions is led by a recent graduate from Vanderbilt University, and it has created a tracking system device that reduces the amount of blood wasted in hospitals due to compliance parameters.

EndoInsight, meanwhile, is bringing to market a novel low-cost carbon dioxide insufflation system that will help reduce the pain and discomfort associated with colonoscopies. Innometrix has cultivated a diagnostic technology that produces a biomechanical snapshot of the female pelvic floor that will give physicians better data before surgery. And Compression Kinetics has created a new type of compression sleeve that uses a shape memory alloy to create a pressure wave to boost circulation throughout the body and decrease peripheral edema.

Each company will get $50,000 in initial seed capital from co-investors Innova and MB Venture Partners. The accelerator program will conclude with “Demo Day” Aug. 14, when the participants will pitch to a group of investors.

Sign-Up For Our Free Email Edition
Get the news first with our daily email


 
Blog Get more from The Daily News
Blog News, Training & Events
RECORD TOTALS DAY WEEK YEAR
PROPERTY SALES 0 218 10,440
MORTGAGES 0 293 13,620
FORECLOSURE NOTICES 0 68 2,712
BUILDING PERMITS 0 393 24,700
BANKRUPTCIES 0 184 10,076
BUSINESS LICENSES 0 62 3,798
UTILITY CONNECTIONS 0 338 14,895
MARRIAGE LICENSES 0 68 3,235

Weekly Edition

Issues | About

The Memphis News: Business, politics, and the public interest.